Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1/2 1

Status

Completed 8Recruiting 6Active not recruiting 5

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Gynecologic 1

Conditions

Breast Neoplasms 3Advanced Breast Cancer 2ER+ HER2- Advanced Breast Cancer 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × AZD9833 × Clear all
NCT07195227 2026-05-29

CADILLAC

MedSIR

Phase 2 Recruiting
150 enrolled
Breast

Breast Neoplasms

NCT05952557 2026-05-28

CAMBRIA-2

AstraZeneca

Phase 3 Recruiting
5,500 enrolled
Breast

Breast Neoplasms

NCT07427394 2026-05-28

SERENA-1b

AstraZeneca

Phase 2 Recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT06380751 2026-05-15

EvoPAR-BR01

AstraZeneca

Phase 3 Recruiting
500 enrolled
Breast

Advanced Breast Cancer

NCT06188520 2026-05-11

CYCAD-1

AstraZeneca

Phase 1/2 Recruiting
564 enrolled
BreastGynecologic

ER+ HER2- Advanced Breast Cancer

NCT05774951 2026-05-08

CAMBRIA-1

AstraZeneca

Phase 3 Recruiting
4,300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡